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B,sOk0m~ Hen~t failure con now bo tmaled e f t ,  t~t it can be d~ff~. 
~no~ In ~al~ls_ ~ _~m,Fr~toma~ kffl ventm~lar (LV)impaJmlnt, 
~m,W~Y 
Me~q_~.b.- We. am ~men~ 7QO0 pa,ent= aged 4~ ~nd above tram Ihe 
O0m~unily in WeS! ~ ~ 011Ert0~nd: 4000 randondy imlecled aged 
4~; 1000 v~ a ~  dU~,ne, m ~ ~ ;  100~ o~¢we~-=; 
an~ I000 ~ "mk facies' ~o~ head farm ~ m. ~ .  ~mene,. 
==o~ O~ angi~). Pafiem asse=m~em ¢lud~ ¢1in¢~ hist. /and exammatmn, 
ECG, and ed~ocanfm~,  uath co~o~r Ito~ and =iPecbal ~ ~l ies .  
~ -  Tbe ~ ¢lotads Hhe I tn~ m the 5rst 2B5~ ~ .  EF= 
~ oc va~e,~ceme~ 
45~pOlp~a~=a~e 40~z254 it 8%) 40~2254(1~%) 7(Y2254t31%) 
I~dkO~dhead l l t la~we 52tt75(L~93~,) 18/175t103%l 5~,'175(32(T%1 
(~t CbJ~4u¢~ L~ (11 8%) lO,~o~ (4 9'%) ~ (16.3%) 
H~gt~m~ gmUp~ 25~06 tB.2%) 15~JO6 t4 g~=~ 22,"306(72%) 
~ :  The We~,-,,:6 of de~n,~ LV sySte~ ~xsfur¢tk~ was I.:;:o 
m the popula~on sample. Ordy 30% of Itmse vd~ose GP had diagnosed heart 
ta~hu~ bed der~m systo~ dysfu~on. Vah,e o~sease was fraque,,~y found 
m ease with a dragnets of heart ~ ,  often as the onty al~normardy 
~ l~tral  Valve Prolapse Recon=Iden~: 
and EpiOemiology in the Fromingham Heart Study 
L_A. Freed. D. Le.ty. R.A. Levme. MG. ~ J.C. Evans. D.L FuJler, 
e_ Lehma~ AJ. 3enlamin. ~assachuseKs Get(eta/Hos~ta/. Boston. A,~L- 
NHLBt3 F t -~ham Heart Stuo~, Fmnvnghan~ MA. USA 
Esttn~tes at th,= prevatence of =~bal valve pm~3se (MVP) generelly, have 
been de~=d ~nt  hosl~.al-based referral popu~K~ns and am as ~ as 7% 
of men and 21% at women. To detew,~ne Ihe ima~alenco at MVP in lt~e germ.we! 
populatio~ d ia~ (:sing cunrent 2D e ~  criteria, we eves- 
ined the ed loca ld t~ of 3487 sub~l~'ls ( 1842 women, 1645 men) in Ihe 
Framingl~m Offspring Study. Mistreat mibal leaflet superior d~splacement in 
systole (D) and leaflet ffdctmess in dtaslasis ('f) were measured. "the sut01ects 
were classified as classic MVP (D >2mm, T ~ Smm), nonclass¢ MVP(D >2 
ms, T < 5 ms), or no MVP (D ~ 2 ms). 
/ ; ~  at Total |%) ~ i%) I~n I%) 
C/ass¢ MVP 46 (13%) 25 (1.4%) 21 (13%) 
~ M V P  37(1.1%) 24(1 3%) 13 (0 8%) 
Compared with the general sample, MVP subjects had s~rmlar age and 
gender distnbutmn and prevalence of hypert~nsio~=, but were significantly 
leaner (,2.6 kgh~ , p = 0.0001). There were no MVP subjects with heart fail- 
ure. one with atrial fibrillation, and one with stroke, compared with population 
prevalences of 0.6. 1.6. and 1 5% 
Conclusions: 1. The prevalenCe of MVP in this healthy unsalected popula- 
tion is fewer than previously reported. 2. Adverse sequelae commonly associ- 
ated with MVP in referral populations are ram in our MVP cases identified in a 
genera( imputation, 
~ A  National Screening Program for the 
Identif ication of  Pemons With Familial 
Hypercholesterolemla in the Netherlands 
M.A.W. Umans-Eckenhausen ~ , J.C. Defesche ~, F. Clind ~, J.J.P. Kaslelein ~. 
The StOEH. the Netherlands: 2 The Academic Medical Center, Amsterdam, 
the Netherlands: 3The Ministry of Health, Rijswijk, the Netherlands 
Background: The Dutch Government encouraged the development of an ac- 
live somenmg program for ~nt i rcat~ of Famtl~ ~de i le~im.~ 
(FH) pts to ensure 0ariy d~gf~lls and tmstme~ to prevent Carff~Ovascuiar 
• sease, 1"~s program is executed mnce 1993 by the StOEH 
Meth(x~ A nat~rvw~te neh,,~o~ of I~,¢1 ¢1i~¢:~ was esla~,she¢l to ~uty  
FH index pit, Su~uen l ly  mtabvei were 1orNery ¢o~l¢te4 ~ =¢f~me~ 
ReW~Afs, 0etweml 1993 0rtcIJ~y 1907 1341 mdml pts midtmt~,  
famly ~LmmO Wa~ ~ in Ie9 latona, Pwlc~u~ rote o~ ~ 
~'~. Num~ at reeves ~mer4xl ~,e0. Num~ of R.I I~ mn~ed !20~ 
(37%). S~ (41%) maim and ~ (SS%I mmm. O! ,~  FH mW~: ~ (~'~) 
~x~t a ¢~k~,o l  tv, g~r then 390 m0~, 37 0~,) ~z0o~t ¢a~ovnzm~, ¢~ 
~ at ~ of ~ca lk~.  For the femal~ IP~e~ nomoem am ~p~cfivmy 
~S (4t %1 and 44 C/%), O~h/10% of R.Ipt= meowed adequm r , ,~w~t p~o~ 
to ~n0,  Aftra ~mtdtcatmn, 03% of pt~ meeiv~l ndequm t~otme~ 
~ sek~v~ a~ efft~m m the ident~=~ o~ ~w ~=et  The mu~t 
~ amqum e~pout¢  ~ ~ me p f~p~=~ p~we m r~ 
e~zease fo~ mo~t pts, ~ such n~ program ten ~ an ~ ~ to tt~ 
ez~mmO pmgrar~ for the prevemmn of c~rdtovascular (hsaxS, 
~ ~no ldn0  and HDL-C!tokmlwrol In a !XopgtaUo~ of 
C P~savols, I Sk~u~nas, V Koulo~d~s, M Toutouza, A Do~lalas, 
S. Paxima¢l~, N G~,  S. Vama, S. Lan~mu, C Slefana~s, 
P. Touts__ ~,~. _. ~ HON~, A~tm~ Unn~a~ G~wece 
aa~x~o~-The advenre m~-t m =me=~g m p,~awna HOL-¢he~ (HOL.Cl 
r~as f~m esu~shed by e l~Wno~ s tu ,~ mama, in .w(ae.,age¢ pe~. 
softs. In co~asl. Ibe mI.Mmn between smokJ~ aml HDL-C nt yotm9 heaJ1~ 
~u~s bes ~ot bee~ adequately mZ~dted, fa offer to fumw, r ~ mis 
msu~, we s~udied 1954 from a Imputabon of 2QO9 ma~e re~,utts of the Greek 
an~, aged 223 ± 2.9 yearn. 
MemOs: Fqasma ~ ~ (total ch0~e~e~, tnQ~,~:endes and HaL-C) 
wee measured and a medical I1islo~y was coml~eted m all recruits. We con- 
sxle~¢l as smoke those t,,~o .=~.'.=,:1 smok~ > 10 c:~amt~ per o~y (r..~) 
for ~t least ~ yea~, wh~e reo'ui~ smolang < 10 C/~ o~ lot < 1 year (n = 55) 
were e~h~ ~om ~e gudy. Mean bedy mass index (BI~) m ~ popumt~o. 
was 23.4 ± 3.3 kgr,~-. 
Resu/ts: Of ~ total populal~n, 759 reo~ (38.8%) were snto~m and 
1195 (61~%) wef~ nof~smokere. No siQ~ifiCa~ differeno~ wt~m found be- 
tweet( ~ ~ non-smokers regaKflng BMI (23.4 :~ 3,3 ve 23.3 ± 32 
kgr/m z, p = NS). a~e (22.2 ~: 3 vs 22.4 ± 2.9 yearn, p = NS) and plasma 
HDL-C (45.4 ~: 12 ~s 45.4 ± 0.6 r~cfl, p = NS). Multiple regres~o~ ar i -  
ses wa~ eml~ Io evah~ate I/le ~ between HDL-C and duratKm 
of smotur~, dady ~ consurnptmn, zdcohof consun'q3tzon, BMI and age. 
Only al~'~hoI cor~m~ was found tO affect HDL-C valUeS ~hJ  (a = 
0096. p = 0 003) in addffion. ~ retalm~ between HDL-C values (now de- 
r~e~ase~er >-3Sm~dlo~ >4Smg~d;) and~ea lomm~ed vanaU~ptu= 
,~,~,:.,~ was eva~ W togis~ regnmUon analy~. A ~ ome~r,o. 
was n~,~ealed be~,een alco~ o:..,-,~mp~n and HDL,C values ~35 mg/~ (B 
= 0.032. p =O.04) as weg as betwe~ HDL-C _>45 m9/ol and ak:otlol ¢onsum~- 
I~n. exerose ar¢l age (e = 0.024. p = 0.05; B = 0.15, p = 0.03 and B = 0.047. 
p = 0.00 mspectM~y). The pamal coe,T,~em o~ conem~n behveen smo~ 
and HOL-C (zero order} was 0.018 (p = NS); whe~ aloohol cormuml~on, BMI 
and age ~re  not in,stied ~n Ihe analys~ (3 ~ oKler), ~s value was -0.0085 
(p = NS). 
~ -  HDL-C is not infk~-~-~ by smoking in young Greek male 
adults. This fact may mdtcate that the adverse effect of smoking in plasma 
HDL-C LS expressed after a ~'~er penod of exposure to smoking, or that it is 
me.tied by ¢~etary facies (Medffenanean diet). 
~ Geographical Variation in Cardiovascular Risk 
Factors in Fa;',~v,t~ With Coronary Heart Oiselme 
in Nine European Countries (EUROASPIRE) 
D. Wood. On behalf of ~ EUROASPIRE invesl*tgators; Impenal College 
School of Medicine, London. UK 
In a nine COuntn/European survey o Czech Republic. Finland, France, Ger- 
many, Hungan/, Italy, Netherlands. SIovema and Spain - there was cons~er- 
able variatiOn in •e prevalence of cardiovascular risk factors in p~tients with 
corona W heart disease. Consecutive patients within 4 diagnsotic ategories 
(CABG, PTCA, acute myocardial ischaemra nd myocardial ischaemia with- 
out infarction) were identified in a sample of ~ within a geogral~'~cet 
area. 3569 patients were interviewed (edlusted response rate 85%) 6 months 
or later after the index event. At inten,,iew the prevalence of current smoking 
ranged from 12% in Spain to 32~'.- in the Netherlands. Overell men smoked 
(21%) more commonly than women (14%). Obesity (BMI >_30 kg/m2) ranged 
from 19% in the Netherlands tn 33% in France Raised blood pressure (SBP 
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:,:.140 and/or DBP 390 mmHg) ranged from 48% in France to 61% in the 
Czech Republic, Elevated plasma total cholesterol (~5.5 stool/I) ranged from 
36% In Spain to 58% In italy, Diabetes ranged from 10% In the Nothedands 
to 27% In Hungary. A family hlstolv of premature CHD In e first degree blood 
relative ranged from 21% In Spain to 57% In Finland, These significant go. 
ogr.phlcal verlntlons In the prevalence of oardlovasculer risk fsctore In CHD 
pntl,,nts acro,s Europe partly reflect he incidence of cardiovascular disease 
In each country, aerie.economic onditions and Iho aHItudes of physicians to 
dsk factor modification and second(try prevention of coronary heart dlsoaso, 
~ ]  Twanty.Yur (1678-1998) Community-wide Tmnde 
................ In the Inoldonoe nnd In,hospital  Cl l l I -FI Ihl l i ty 
Rlt te l  (CFR'I) AlllOgllliod With Conge l t lv l  Heart 
Falluro (CHF) Complicating Acute MyOOllrdlal 
Infarction (AMI): The Womester Heart Attaek 
Study 
M. Hottoh. J. ¥~rzebskl, R, Goldboro, T, Meyer, J, Gore, The LIn/vwxify of 
Mes~ch~aelta M~It~I School, Woroo~ter, MA, USA 
Bl~¢t¢#lmUnd; Limited and re~ent population.based ata are ~vellsble about 
changes over time in the Incidence and CFR'R of CHF complloallng AML The 
goals 01 this mUlll.hospitsl commgnlty.wlde study warn to das~rlba temperer 
trends In the Incldenca and CFR's at CHF complloetlng AMI from a pepuia, 
lion.based perepeellve, 
Mefho~l~: 6,797 pallents with vslldsled AMI, and wdhout a pnor history 
0l CHF, hospitalized in ~tl Wome~ter, MA, metropolitan hospitals (1090 con, 
~lgS estimate =~ 470,000) In ten pen0ds between the years 1975 end 1995 
comprised the study sample, 
R~u~;  Declines in the unadjusted incidence retaa as woII as CFR's o! 
CHF were zeen In the five aggregated study penods: 
19'15f7S lp(tl/a4 1988,'88 1090/91 1083/95 
In -  1402) (n = 1431.1) in -  1231) in .  12~,0) in = 1407) 
In¢ld~n~ r~te= (~l  3n3 43,6 3?~ 35(t 33 1 
In.hoapIt~l CFR I%) I? ~ 15,4 10,1 131 112 
ConCtu,~vl: The reSUltS et this community-wide observational study sug- 
gest ancouregLng declines In the occurrence end hoapltal death rates of CHF 
In the setting of AMI, Despite those encouraging trende, CHF is a frequent 
complication of AMI, emphasizing the continued importance of continued sec- 
ondary prevention efforts. 
~ Coronar.i Disease Patients With Low 
Socioe©onom~© Status Have Higher Out-of-Pocket 
Medicat ion Expanses and Higher Non-cempllence 
Rates 
C,Y, Tung, L,C, Lam, N, ( :lapp-Channing, R, Harwood, R, Williams, 
J, Barefoot, I, Stagier, D. t. Malk, DukeCtinicaiFteseamh '~s~tute, Durham, 
North Carolina, USA 
Background: The mediators by whlc,~ socioeconomic status (SES) affect car- 
diac outcomes remain unclear. The purpose ot the study was to determine the 
effect ol low SES on out-of-pocket medication expenses and compliance. 
Methods: We prospectively studied 523 patients with coth proven coronary 
disease who wore treated medically In sltucturecl interviews, patients were 
e~ked about their average monthly ,~ut-of-pocket medication expenses and 
whether they have cut ('/own or stopped taking their medications because of 
cost. 
Results: 
Ed~.lcation Mods' C~,ltdown Incomo Mods' Cutdown 
6 yrs $119 .~B% - 10 k $107 20% 
• -1~ yrs $88 10% 10 k-20 k $109 15% 
13-16 yrs  $S6 5% 20 k-45 k $58 3% 
• 16 yts $66 5% .45 k $71 2% 
• Rverage monthly out-or-packet me¢lk~atton expenses, 
Conclusion: Out-of-pocket medication expenses for coronary disease pa- 
tients o1 low SES were nearly twice as high as those with higher SES The 
higher medication cost was associated with a five to ten fold higher medical 
non-compliance. Non-compliance with medieat herapy could inpart account 
for the woreo prognosis of low SES coronary disease patients, 
~ Socioeconomic Status and Medical Care Use In 
Coronary Disease Patients 
C.Y. Tung, L.C. Lam, N Clapp-Channing, B, Lytle, R. Williams, J. Barefoot, 
I. Siegler, D.B. Mark. Duke Clinical Research Institute, Durham, North 
Carolina, USA 
Background: Low socioeconomic status (SES) is associated with increased 
cardiovascular mortality, However, the mediators by which SES affect cardiac 
outcomes remain unsettled, One potential mediator Is pattern of medical cam 
USe, 
Methods: We pmspoctlvaly studied 523 patients with oath proven coronary 
disease who were treated medically. Medical care use was assessed at 6 
months. The definition for low SES was an income .:$10,000/yr and <9 wars 
of education, 
Results: Patients In the low SES group were older (68 ve, 63, p ,~ 0 01), had 
more hypedenslcn (78% va 57%, p < 0,001), were more likely to be lemala 
(49% ve 31%, p ,=, 0,0QOl), and more likely to t~ blick (34% vii 15%, p .~ 
0,001), Even thoug h the total number of outpr~tlent vlsite was not slgntl¢antty 
different (5,1 vs, 8, p = 0,73), the low SES group required more ER visits (0,3 
va, 0,1R, p .  0,01), but received lower ¢am~ac rahab viaitl (0 ve. 2.8, p - 
0005), There was no difference in hospllallzatlons, 
Conclusion: Coronary disease patients with low SES had more acute care 
vlslta, bgt received fewer preventive visit8 them other Ipet!ents, Thia different 
pattern of medloat care uzre could, in pad, account for the worse prognosis 
observed for law SES coronary disease patients, 
~ High Pmva!emm O! Left Ventdcular Hyper t rophy 
In Young Urban Black Man With Hypertens ion 
W,S, Post, J,L, Weiss, R~, Blumenthal, G. Gorstenblilh, A.R. CopseS, 
M,C, Roary, S, Hall, MT  Kim, M.N. Hi!l. Johns H~ms &4~)d/,cal tnstitutmns. 
Baltimore, Mary/and, USA 
Left ventriculsr hypertrophy (LVH) in hypertensive populations iS a potent 
predic;tor el adverse cardiovascular events, en imPortant pre~nm~r for the 
development of systolic and diastolic dysfunction, end may in l l~  the se- 
lectioh el appropriate therapy. Although its prevalence in some hyperten.~ve 
populations is described, the prevalence of LVH in young black hypeflensn~ 
men is not, 
We evaluated the prevalence of LVH in hypertensive young black men 18 
to 54 years old in East Baltimore who were ~rticipating in a ra l l~  study 
evaluating the effectiveness of a comprehensive community health wo~ker- 
nurse prectioner-phystcian team approach to Iowe~ blcocl pressure IBP) and 
decrease cardiovascular outcomes in this high risk group. Echecan:~ 
LV mass (LVM) was measured using the 2.D 5/6 area.length method. LVM 
was indexed ta height and LVH was defined as LVM index ~-~43 g~nn. ECG- 
LVH was detemliced using the Comell voltage dtefia. RaVL + Sv3 > 28 mV. 
O1 the hrst 106 men with hyT..~tl~nsion (HTN) at the baseline exam (SBP 
~: t 40 or DBP ~. 90) 9 with inadequate chocam'iogrems were excluded. In the 
mm~.ining 97, mean age was 3.q ~. 5 yearn, mean BP 154 ~L 19/104 ± 13 
mmHg and mean body mass index 25.9 =: 5.5 kg]n~.. Mean LVM was 214 ~. 
62gandmeanLVMindex 121 • 3401m.Theprevalencoolechecardiographic 
LVH was 22%. The prevalence of ECG-LVH was 14%. with a sensitivity of 28=0 
and specificity of 90% comparecl with echocardiographic LVH The correlation 
between sap and LVM index was r = 0.26, p = 0.0t, 
The Ngh prevalence ot echocardiograph=c LVH in inner city black hyper- 
rensive men may have important implications lot the evaluation and treatment 
el HTN and its consequences in this young high risk group. 
~ Excessive Prevalence of  Coronary Disease Risk 
Factors in Black Families With Premature 
Coronary Heart  Disease 
R.S, Blumenthal, ID.M. Becket, R.M. Yook, T.F. Moy, B.G Kral, L.C. Becker. 
The Johns Hopkins Medical Institutions. Bedsore. Maryland, USA 
Premature familial CHD and its associated risk factors have been studied al- 
most exclusively in white families. To determine the prevalence in blacks el 
hypertension end lipid abnormalities known to contribute to the risk of pre- 
mature CHD, 161 apparently healthy black siblings (SIBS) from 86 probands 
with CHD .60 years o1 age were examined and compared with sex and race 
matched reference populahons from the Third National Health and Nutntion 
Examination Survey (NHANES). Black SIBS had a mean age of 46 ~ 8 years, 
an educational level ot 12.8 ± 2 years, and were all free of known CHD. 
The data in the table show an excess prevalence l hypercholesterolemla 
and hypedension in black families with a history of premature CHD relative to 
black population orms, Aggres.~ive screening and treatment in black families 
~IBS NHANES p-vatue 
Black men (n = ~,4) 
LDL-C ~ 160 mg/dl 54% 17% - 0.01 
HDL-C. 35 rhg/dL 11% 11% 0.90 
Hypertension 59°0 34°0 . 001 
Black women (n = 107) 
LDL-C ~ 160 rag/d1 36% 15% •:0.01 
ttDL-C • 35 mg/dl 7°0 4°0 0.30 
Hypertension 52% 27% • 0,01 
